Showing results (161-170 of 525) with videos related to
Sort By:
Pageof 53
Prostaglandins, Leukotrienes, and Medicine|September 1, 1982
Hypertension and beneficial treatment with beta-blocking agents does not change the platelet sensitivity to the antiaggregatory prostaglandinsH Sinzinger, P Fitscha, J KalimanJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Low cholesterol and cancerH Kritz, C Zielinski, H SinzingerThrombosis Research|November 1, 1990
Autologous platelet-labeling in thrombocytopeniaH Sinzinger, I Virgolini, H VinazzerThrombosis Research|February 15, 1990
Platelet kinetics in patients with atherosclerosisH Sinzinger, I Virgolini, P FitschaThe British Journal of Radiology|March 1, 1982
Radiography and bone scintigraphy in multiple myeloma: a comparative analysisH Ludwig, W Kumpan, H SinzingerProstaglandins, Leukotrienes, and Essential Fatty Acids|October 26, 2000
Why is glycated LDL more sensitive to oxidation than native LDL? A comparative studyG Sobal, J Menzel, H SinzingerBreast (Edinburgh, Scotland)|February 18, 2004
Nuclear medicine and breast cancer: a review of current strategies and novel therapiesP Berghammer, R Obwegeser, H SinzingerJournal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|December 1, 1994
Synergistic antiplatelet action of nitric oxide (NO) with PGD2 and its metabolite PGJ2--relevance for cerebral circulation?M Rodrigues, P Fitscha, H SinzingerFolia Haematologica (Leipzig, Germany : 1928)|January 1, 1978
[The question of the diagnostic value of increased erythrocyte enzymes in leukemia]H Pietschmann, H Sinzinger, K SchneiderActa Anatomica|January 1, 1976
[A combined calcium--fat staining with determination of vessel wall permeability]C Dadak, H Sinzinger, W FeiglPageof 53